التفاصيل البيبلوغرافية
| العنوان: |
Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccination With BNT162b2 Increased Risk of Bell's Palsy: A Nested Case-Control and Self-Controlled Case Series Study. |
| المؤلفون: |
Wan, Eric Yuk Fai, Chui, Celine Sze Ling, Ng, Vanessa Wai Sei, Wang, Yuan, Yan, Vincent Ka Chun, Lam, Ivan Chun Hang, Fan, Min, Lai, Francisco Tsz Tsun, Chan, Esther Wai Yin, Li, Xue, Wong, Carlos King Ho, Chung, Raccoon Ka Cheong, Cowling, Benjamin John, Fong, Wing Chi, Lau, Alexander Yuk Lun, Mok, Vincent Chung Tong, Chan, Frank Ling Fung, Lee, Cheuk Kwong, Chan, Lot Sze Tao, Lo, Dawin |
| المصدر: |
Clinical Infectious Diseases; 2/1/2023, Vol. 76 Issue 3, pe291-e298, 8p |
| مصطلحات موضوعية: |
COVID-19, CONFIDENCE intervals, COVID-19 vaccines, CASE-control method, ACQUISITION of data, DISEASE incidence, BELL'S palsy, RISK assessment, MESSENGER RNA, MEDICAL records, DESCRIPTIVE statistics, RESEARCH funding, LOGISTIC regression analysis, ODDS ratio, POISSON distribution, DISEASE risk factors |
| مصطلحات جغرافية: |
HONG Kong (China) |
| مستخلص: |
Background Observable symptoms of Bell's palsy following vaccinations arouse concern over the safety profiles of novel coronavirus disease 2019 (COVID-19) vaccines. However, there are only inconclusive findings on Bell's palsy following messenger (mRNA) COVID-19 vaccination. This study aims to update the previous analyses on the risk of Bell's palsy following mRNA (BNT162b2) COVID-19 vaccination. Methods This study included cases aged ≥16 years with a new diagnosis of Bell's palsy within 28 days after BNT162b2 vaccinations from the population-based electronic health records in Hong Kong. Nested case-control and self-controlled case series (SCCS) analyses were used, where the association between Bell's palsy and BNT162b2 was evaluated using conditional logistic and Poisson regression, respectively. Results Totally 54 individuals were newly diagnosed with Bell's palsy after BNT162b2 vaccinations. The incidence of Bell's palsy was 1.58 (95% confidence interval [CI], 1.19–2.07) per 100 000 doses administered. The nested case-control analysis showed significant association between BNT162b2 vaccinations and Bell's palsy (adjusted odds ratio [aOR], 1.543; 95% CI, 1.123–2.121), with up to 1.112 excess events per 100 000 people who received 2 doses of BNT162b2. An increased risk of Bell's palsy was observed during the first 14 days after the second dose of BNT162b2 in both nested case-control (aOR, 2.325; 95% CI, 1.414–3.821) and SCCS analysis (adjusted incidence rate ratio, 2.44; 95% CI, 1.32–4.50). Conclusions There was an overall increased risk of Bell's palsy following BNT162b2 vaccination, particularly within the first 14 days after the second dose, but the absolute risk was very low. [ABSTRACT FROM AUTHOR] |
|
Copyright of Clinical Infectious Diseases is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
